世界のアメーバ症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Amebiasis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3790 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、アメーバ症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（メトロニダゾール、パロモマイシン、チニダゾール、その他）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アメーバ症治療薬の市場動向 ・企業の競争状況、市場シェア ・アメーバ症治療薬の種類別市場規模と予測2016-2027（メトロニダゾール、パロモマイシン、チニダゾール、その他） ・アメーバ症治療薬の用途別市場規模と予測2016-2027（病院、薬局） ・アメーバ症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・アメーバ症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アメーバ症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アメーバ症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・アメーバ症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Dr. Reddy’s Laboratories、Mission Pharmacal、Aceto Corporation、Mylan Pharmaceuticals、Impax Laboratories、Pfizer、Sanofi、Lupin Pharmaceuticals、Glenmark Pharmaceuticals、Sun Pharmaceutical、Heritage Pharmaceuticals） ・結論

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.

Market Analysis and Insights: Global Amebiasis Therapeutics Market
The global Amebiasis Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amebiasis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amebiasis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amebiasis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amebiasis Therapeutics market.

Global Amebiasis Therapeutics Scope and Market Size
Amebiasis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amebiasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Metronidazole
Paromomycin
Tinidazole
Other

Segment by Application
Hospital
Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amebiasis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Metronidazole
1.2.3 Paromomycin
1.2.4 Tinidazole
1.2.5 Other
1.3 Market by Application
1.3.1 Global Amebiasis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Amebiasis Therapeutics Market Perspective (2016-2027)
2.2 Amebiasis Therapeutics Growth Trends by Regions
2.2.1 Amebiasis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amebiasis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Amebiasis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Amebiasis Therapeutics Industry Dynamic
2.3.1 Amebiasis Therapeutics Market Trends
2.3.2 Amebiasis Therapeutics Market Drivers
2.3.3 Amebiasis Therapeutics Market Challenges
2.3.4 Amebiasis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Amebiasis Therapeutics Players by Revenue
3.1.1 Global Top Amebiasis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Amebiasis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Amebiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amebiasis Therapeutics Revenue
3.4 Global Amebiasis Therapeutics Market Concentration Ratio
3.4.1 Global Amebiasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amebiasis Therapeutics Revenue in 2020
3.5 Amebiasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Amebiasis Therapeutics Product Solution and Service
3.7 Date of Enter into Amebiasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Amebiasis Therapeutics Breakdown Data by Type
4.1 Global Amebiasis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Amebiasis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Amebiasis Therapeutics Breakdown Data by Application
5.1 Global Amebiasis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Amebiasis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Amebiasis Therapeutics Market Size (2016-2027)
6.2 North America Amebiasis Therapeutics Market Size by Type
6.2.1 North America Amebiasis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Amebiasis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Amebiasis Therapeutics Market Size by Type (2016-2027)
6.3 North America Amebiasis Therapeutics Market Size by Application
6.3.1 North America Amebiasis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Amebiasis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Amebiasis Therapeutics Market Size by Application (2016-2027)
6.4 North America Amebiasis Therapeutics Market Size by Country
6.4.1 North America Amebiasis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Amebiasis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Amebiasis Therapeutics Market Size (2016-2027)
7.2 Europe Amebiasis Therapeutics Market Size by Type
7.2.1 Europe Amebiasis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Amebiasis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Amebiasis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Amebiasis Therapeutics Market Size by Application
7.3.1 Europe Amebiasis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Amebiasis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Amebiasis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Amebiasis Therapeutics Market Size by Country
7.4.1 Europe Amebiasis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Amebiasis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Amebiasis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Amebiasis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Amebiasis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amebiasis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amebiasis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Amebiasis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Amebiasis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amebiasis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amebiasis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Amebiasis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Amebiasis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amebiasis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Amebiasis Therapeutics Market Size (2016-2027)
9.2 Latin America Amebiasis Therapeutics Market Size by Type
9.2.1 Latin America Amebiasis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Amebiasis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Amebiasis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Amebiasis Therapeutics Market Size by Application
9.3.1 Latin America Amebiasis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Amebiasis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Amebiasis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Amebiasis Therapeutics Market Size by Country
9.4.1 Latin America Amebiasis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Amebiasis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Amebiasis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Amebiasis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Amebiasis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amebiasis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amebiasis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Amebiasis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Amebiasis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amebiasis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amebiasis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Amebiasis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Amebiasis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amebiasis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dr. Reddy’s Laboratories
11.1.1 Dr. Reddy’s Laboratories Company Details
11.1.2 Dr. Reddy’s Laboratories Business Overview
11.1.3 Dr. Reddy’s Laboratories Amebiasis Therapeutics Introduction
11.1.4 Dr. Reddy’s Laboratories Revenue in Amebiasis Therapeutics Business (2016-2021)
11.1.5 Dr. Reddy’s Laboratories Recent Development
11.2 Mission Pharmacal
11.2.1 Mission Pharmacal Company Details
11.2.2 Mission Pharmacal Business Overview
11.2.3 Mission Pharmacal Amebiasis Therapeutics Introduction
11.2.4 Mission Pharmacal Revenue in Amebiasis Therapeutics Business (2016-2021)
11.2.5 Mission Pharmacal Recent Development
11.3 Aceto Corporation
11.3.1 Aceto Corporation Company Details
11.3.2 Aceto Corporation Business Overview
11.3.3 Aceto Corporation Amebiasis Therapeutics Introduction
11.3.4 Aceto Corporation Revenue in Amebiasis Therapeutics Business (2016-2021)
11.3.5 Aceto Corporation Recent Development
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Company Details
11.4.2 Mylan Pharmaceuticals Business Overview
11.4.3 Mylan Pharmaceuticals Amebiasis Therapeutics Introduction
11.4.4 Mylan Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021)
11.4.5 Mylan Pharmaceuticals Recent Development
11.5 Impax Laboratories
11.5.1 Impax Laboratories Company Details
11.5.2 Impax Laboratories Business Overview
11.5.3 Impax Laboratories Amebiasis Therapeutics Introduction
11.5.4 Impax Laboratories Revenue in Amebiasis Therapeutics Business (2016-2021)
11.5.5 Impax Laboratories Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Amebiasis Therapeutics Introduction
11.6.4 Pfizer Revenue in Amebiasis Therapeutics Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Amebiasis Therapeutics Introduction
11.7.4 Sanofi Revenue in Amebiasis Therapeutics Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Details
11.8.2 Lupin Pharmaceuticals Business Overview
11.8.3 Lupin Pharmaceuticals Amebiasis Therapeutics Introduction
11.8.4 Lupin Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021)
11.8.5 Lupin Pharmaceuticals Recent Development
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Details
11.9.2 Glenmark Pharmaceuticals Business Overview
11.9.3 Glenmark Pharmaceuticals Amebiasis Therapeutics Introduction
11.9.4 Glenmark Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021)
11.9.5 Glenmark Pharmaceuticals Recent Development
11.10 Sun Pharmaceutical
11.10.1 Sun Pharmaceutical Company Details
11.10.2 Sun Pharmaceutical Business Overview
11.10.3 Sun Pharmaceutical Amebiasis Therapeutics Introduction
11.10.4 Sun Pharmaceutical Revenue in Amebiasis Therapeutics Business (2016-2021)
11.10.5 Sun Pharmaceutical Recent Development
11.11 Heritage Pharmaceuticals
11.11.1 Heritage Pharmaceuticals Company Details
11.11.2 Heritage Pharmaceuticals Business Overview
11.11.3 Heritage Pharmaceuticals Amebiasis Therapeutics Introduction
11.11.4 Heritage Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021)
11.11.5 Heritage Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Amebiasis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Metronidazole
Table 3. Key Players of Paromomycin
Table 4. Key Players of Tinidazole
Table 5. Key Players of Other
Table 6. Global Amebiasis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Amebiasis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Amebiasis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Amebiasis Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Amebiasis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Amebiasis Therapeutics Market Share by Regions (2022-2027)
Table 12. Amebiasis Therapeutics Market Trends
Table 13. Amebiasis Therapeutics Market Drivers
Table 14. Amebiasis Therapeutics Market Challenges
Table 15. Amebiasis Therapeutics Market Restraints
Table 16. Global Amebiasis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Amebiasis Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Amebiasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amebiasis Therapeutics as of 2020)
Table 19. Ranking of Global Top Amebiasis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Amebiasis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Amebiasis Therapeutics Product Solution and Service
Table 23. Date of Enter into Amebiasis Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Amebiasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Amebiasis Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Amebiasis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Amebiasis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Amebiasis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Amebiasis Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Amebiasis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Amebiasis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Amebiasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Amebiasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Amebiasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Amebiasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Amebiasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Amebiasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Amebiasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Amebiasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Amebiasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Amebiasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Amebiasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Amebiasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Amebiasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Amebiasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Amebiasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Amebiasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Amebiasis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Amebiasis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Amebiasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Amebiasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Amebiasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Amebiasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Amebiasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Amebiasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Amebiasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Amebiasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Amebiasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Amebiasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Amebiasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Amebiasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Dr. Reddy’s Laboratories Company Details
Table 64. Dr. Reddy’s Laboratories Business Overview
Table 65. Dr. Reddy’s Laboratories Amebiasis Therapeutics Product
Table 66. Dr. Reddy’s Laboratories Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Dr. Reddy’s Laboratories Recent Development
Table 68. Mission Pharmacal Company Details
Table 69. Mission Pharmacal Business Overview
Table 70. Mission Pharmacal Amebiasis Therapeutics Product
Table 71. Mission Pharmacal Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Mission Pharmacal Recent Development
Table 73. Aceto Corporation Company Details
Table 74. Aceto Corporation Business Overview
Table 75. Aceto Corporation Amebiasis Therapeutics Product
Table 76. Aceto Corporation Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Aceto Corporation Recent Development
Table 78. Mylan Pharmaceuticals Company Details
Table 79. Mylan Pharmaceuticals Business Overview
Table 80. Mylan Pharmaceuticals Amebiasis Therapeutics Product
Table 81. Mylan Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Mylan Pharmaceuticals Recent Development
Table 83. Impax Laboratories Company Details
Table 84. Impax Laboratories Business Overview
Table 85. Impax Laboratories Amebiasis Therapeutics Product
Table 86. Impax Laboratories Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Impax Laboratories Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Amebiasis Therapeutics Product
Table 91. Pfizer Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Amebiasis Therapeutics Product
Table 96. Sanofi Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Lupin Pharmaceuticals Company Details
Table 99. Lupin Pharmaceuticals Business Overview
Table 100. Lupin Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Lupin Pharmaceuticals Recent Development
Table 102. Glenmark Pharmaceuticals Company Details
Table 103. Glenmark Pharmaceuticals Business Overview
Table 104. Glenmark Pharmaceuticals Amebiasis Therapeutics Product
Table 105. Glenmark Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Glenmark Pharmaceuticals Recent Development
Table 107. Sun Pharmaceutical Company Details
Table 108. Sun Pharmaceutical Business Overview
Table 109. Sun Pharmaceutical Amebiasis Therapeutics Product
Table 110. Sun Pharmaceutical Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Sun Pharmaceutical Recent Development
Table 112. Heritage Pharmaceuticals Company Details
Table 113. Heritage Pharmaceuticals Business Overview
Table 114. Heritage Pharmaceuticals Amebiasis Therapeutics Product
Table 115. Heritage Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Heritage Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amebiasis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Metronidazole Features
Figure 3. Paromomycin Features
Figure 4. Tinidazole Features
Figure 5. Other Features
Figure 6. Global Amebiasis Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Amebiasis Therapeutics Report Years Considered
Figure 10. Global Amebiasis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Amebiasis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Amebiasis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Amebiasis Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Amebiasis Therapeutics Market Share by Players in 2020
Figure 15. Global Top Amebiasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amebiasis Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Amebiasis Therapeutics Revenue in 2020
Figure 17. Global Amebiasis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Amebiasis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Amebiasis Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Amebiasis Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Amebiasis Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Amebiasis Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Amebiasis Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Amebiasis Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Amebiasis Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Amebiasis Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Amebiasis Therapeutics Market Share by Region (2016-2027)
Figure 39. China Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Amebiasis Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Amebiasis Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Amebiasis Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Amebiasis Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Amebiasis Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Amebiasis Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Amebiasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Dr. Reddy’s Laboratories Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 59. Mission Pharmacal Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 60. Aceto Corporation Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 61. Mylan Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 62. Impax Laboratories Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 65. Lupin Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 66. Glenmark Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 67. Sun Pharmaceutical Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 68. Heritage Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---